The psoriasis disability index in Chinese patients: Contribution of clinical and psychological variables

International Journal of Dermatology

Volumn 44, Issue 11, 2005, Pages 925-929

  Yang, Yong ^a   Koh, David ^a   Khoo, Lawrence ^a   Nyunt, Shwe Zin ^a   Ng, Vivian ^a   Goh, Chee Leok ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; CHINESE; DEMOGRAPHY; DEPRESSION; DISABILITY; DISEASE SEVERITY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PSORIASIS; PSORIASIS DISABILITY INDEX; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SCORING SYSTEM;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANALYSIS OF VARIANCE; DISABILITY EVALUATION; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SINGAPORE; STRESS, PSYCHOLOGICAL;

EID: 28444450904     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02237.x     Document Type: Article

References (29)

1. Sander HM, Morris LF, Phillips CM, et al. The annual cost of psoriasis. J Am Acad Dermatol 1993; 28: 422-425.
2. Kurwa HA, Finlay AY. Dermatology in-patient management greatly improves life quality. Br J Dermatol 1995; 133: 575-578.
3. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-850.
4. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14: 485-496.
5. Rapp SR, Exum ML, Reboussin DM, et al. The physical, psychological and social impact of psoriasis. J Health Psychol 1997; 2: 525-537.
6. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-407.
7. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol 1997; 36: 259-262.
8. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 1995; 34: 700-703.
9. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63.
10. Richards HL, Fortune DG, Griffiths CE, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001; 50: 11-15.
11. Finlay AY, Kelly SE. Psoriasis - an index of disability. Clin Exp Dermatol 1987; 12: 8-11.
12. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Dermatol Venereol 1995b; 75: 240-243.
13. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. Br Med J 1996; 313: 919-921.
14. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of Sickness Impact Profile and Psoriasis Disability Index in Psoriasis. Br J Dermatol 1990; 123: 751-756.
15. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
16. Lewis G, Wessely S. Comparison of the General Health Questionnaire and the Hospital Anxiety and Depression Scale. Br J Psychiatry 1990; 157: 860-864.
17. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
18. Statistical Products and Service Solutions, Inc. SPSS for Windows, Version 10.0. Chicago: SPSS, 2000.
19. Wahl A, Moum T, Hanestad BR, Wiklund I. The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis. Qual Life Res 1999; 8: 319-326.
20. Johnson G, Burvill PW, Anderson CS, et al. Screening instruments for depression and anxiety following stroke. Experience in the Perth community stroke study. Acta Psychiatr Scand 1995; 91: 252-257.
21. Silverstone PH. Poor efficacy of the Hospital Anxiety and Depression Scale in the diagnosis of major depressive disorder in both medical and psychiatric patients. J Psychosom Res 1994; 38: 441-450.
22. Price ML, Mottahedin I, Mayo PR. Can psychotherapy help with psoriasis? Clin Exp Dermatol 1991; 16: 114-1117.
23. Fortune DG, Main QJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 1137: 755-760.
24. Fortune DG, Richards HL, Main CJ, Griffiths CE. Pathological worrying, illness perceptions and disease severity in patients with psoriasis. Br J Health Psychol 2000; 5: 71-82.
25. Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav 2000; 70: 567-571.
26. McKenna KE, Stern RS. The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol 1997; 36: 388-394.
27. Ellis CN, Mordin MM, Adler EY. Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial. Am J Clin Dermatol 2003; 4: 131-139.
28. Van de Kerkhof PC. The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity: persisting areas of confusion. Br J Dermatol 1992; 137: 661-662.
29. Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 1999; 141: 185-191.